Phase 1, single-dose escalating study of marzeptacog alfa (activated), a recombinant factor VIIa variant, in patients with severe hemophilia.
J Thromb Haemost
; 16(10): 1984-1993, 2018 10.
Article
in En
| MEDLINE
| ID: mdl-30151972
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Coagulants
/
Factor VIIa
/
Hemophilia B
/
Hemophilia A
Type of study:
Clinical_trials
/
Diagnostic_studies
Limits:
Adolescent
/
Adult
/
Humans
/
Male
/
Middle aged
Country/Region as subject:
Africa
/
America do norte
/
Europa
Language:
En
Journal:
J Thromb Haemost
Journal subject:
HEMATOLOGIA
Year:
2018
Document type:
Article
Affiliation country: